Oscar Rubén Treviño-Montemayor

Oscar Rubén Treviño-Montemayor

Auto-generated profile, based on publicly available information

Oscar Rubén Treviño-Montemayor

B Obstetrics Service, Hospital Universitario 'Dr. José Eleuterio González', Universidad Autónoma de Nuevo León , Madero y Gonzalitos Sn, Colonia Mitras Centro, Monterrey , N.L. C.P. 64460 , Mexico

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2016 in Hematology
Verified
Journal Article
Closed access
CGCesar Homero Gutierrez-Aguirre
Cesar Homero Gutierrez-Aguirre
JGJosé Alberto García-Lozano
José Alberto García-Lozano
OTOscar Rubén Treviño-Montemayor
Oscar Rubén Treviño-Montemayor
JIJosé Luis Iglesias-Benavides
José Luis Iglesias-Benavides
OCOlga Graciela Cantú-Rodríguez
Olga Graciela Cantú-Rodríguez
DGDavid Gómez-Almaguer
David Gómez-Almaguer
Objective: To compare serum ferritin (SF) concentrations and other hematological parameters between patients with preeclampsia (PE) and normal pregnant women of the same gestational period who received supplemental iron during pregnancy. Methods: Prospective, comparative, observational pilot study that included 31 women with PE and 30 healthy pregnant women, at 20 weeks’ of gestation. Ferritin, iron and complete blood cell count were compared between groups. Results: In comparison with controls, preeclamptic patients had a higher weight, body mass index, and arterial pressure. Serum ferritin and serum iron were higher in patients with PE (median: 36.5 μg/l vs. 20.9 μg/l and 103.9 μg/dl vs. 90.8 μg/dl) with a significant difference (P = 0.019 and P = 0.345). SF values >40 μg/l correlated with PE (r = 0.281; P = 0.032). A platelet count less than 100 × 109/l was higher in the PE group than in the control group (13% vs. 3%, P = 0.354). Conclusion: Higher SF levels, despite being within normal range, were associated with PE. The incidence of thrombocytopenia was higher in preeclamptic women, however, the remaining hematological parameters were similar in both groups.

14 November 2011 in European Journal of Haematology
Verified
Journal Article
Closed access
PDF file
OCOlga G. Cantú-Rodríguez
Olga G. Cantú-Rodríguez
CGCesar Homero Gutierrez-Aguirre
Cesar Homero Gutierrez-Aguirre
JJJosé C. Jaime-Pérez
José C. Jaime-Pérez
OTOscar R. Treviño-Montemayor
Oscar R. Treviño-Montemayor
SMSylvia A. Martínez-Cabriales
Sylvia A. Martínez-Cabriales
DGDavid Gómez-Almaguer
David Gómez-Almaguer

1 January 2017 in Medicina Universitaria
Verified
Journal Article
Open access
RAR. Ambriz-López
R. Ambriz-López
GGG. Guerrero-González
G. Guerrero-González
CRC.G. Rodríguez-Valero
C.G. Rodríguez-Valero
OTO.R. Treviño-Montemayor
O.R. Treviño-Montemayor
AGA. Guzmán-López
A. Guzmán-López
DSD. Saldívar-Rodríguez
D. Saldívar-Rodríguez

10 March 2015 in Psychology, Health & Medicine
Verified
Journal Article
Closed access
OCOlga Graciela Cantú-Rodríguez
Olga Graciela Cantú-Rodríguez
MSMónica Sánchez-Cárdenas
Mónica Sánchez-Cárdenas
OTOscar Rubén Treviño-Montemayor
Oscar Rubén Treviño-Montemayor
CGCesar Homero Gutierrez-Aguirre
Cesar Homero Gutierrez-Aguirre
LTLuz Tarín-Arzaga
Luz Tarín-Arzaga
DGDavid Gómez-Almaguer
David Gómez-Almaguer
The role of outpatient hematopoietic stem cell transplantation (HSCT) as a therapeutic tool has been strengthened significantly because of the increasing number of patients undergoing this treatment. Due the very nature of this procedure, one of the aspects that should not be overlooked is the quality of life (QOL) of patients undergoing HSCT. Thus, one must consider not only health status after treatment, but also, the psychosocial implications for the patient. This is an observational, longitudinal, and prospective study to assess QOL in patients undergoing outpatient HSCT vs. similar patients receiving medical treatment (MxTx). By applying the COOP/WONKA charts on five occasions (pre-HSCT/initial, post-HSCT/first month, and at 3, 6, and 9 months), thirty-eight patients were analysed, 19 with HSCT and 19 with MxTx with no differences in age, gender or diagnosis. The initial survey found significant differences only in pain perception, which was higher in the HSCT group (p = .08); at the first month, there was a greater tendency for feelings of depression or anxiety in the HSCT group (p = .016), with more limitations in social (p = .003) and daily (p = .044) activities. From 3 months post-HSCT, the results were very similar. The differences persisted only in the area of social activities. Four patients developed graft-versus-host disease with no significant difference in the scores obtained compared to other transplant patients at 3, 6, and 9 months (p = .26) of follow-up.

1 February 2012 in Transplantation and Cellular Therapy
Verified
Journal Article
Open access
OCO.G. Cantú-Rodríguez
O.G. Cantú-Rodríguez
OTO.R. Treviño-Montemayor
O.R. Treviño-Montemayor
FLF. Lavalle-González
F. Lavalle-González
AZA. Zapata-Garrido
A. Zapata-Garrido
CGC.H. Gutiérrez-Aguirre
C.H. Gutiérrez-Aguirre
JVJ.Z. Villarreal-Pérez
J.Z. Villarreal-Pérez